artemether-lumefantrine + Mosquirixs for malaria, falciparum

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 May 2024: Trial registered, NCT06424002

The trials

NCT06424002: The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children

State
State not given
Phase
Phase 4
People
5,400 planned
Started
1 Jun 2024
Primary completion
20 Dec 2024
Arms
RTS,S/AS01 Vaccine plus artemether-lumefantrine
Results
None posted
  1. 21 May 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.